Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen, DuPont Join In Genomics Research For Crop Protection


NEW HAVEN, Conn.--CuraGen and DuPont Agricultural Enterprise have signed a collaborative research agreement to explore the application of genomics to enhance the discovery and development of crop protection products.

"We believe that genomics will accelerate DuPont's effort to discover and develop novel, environmentally safe crop-protection products with optimal specificity for target organisms," said Elmo Beyer, DuPont Agricultural's vice-president for global research and development.

Under the agreement, CuraGen will use its suite of proprietary processes, technologies, and bioinformatics to elucidate and characterize the genetic components and metabolic pathways underlying the action of a new DuPont crop protection product. Financial terms were not disclosed.

Greg Went, executive vice president and cofounder of Cura Gen, said that because of the company's association with Pioneer Hi-Bred, "the potential exists for world-class synergy. Each party brings re sources, complementary knowledge, and experience in chemistry, genetics, and genomics technology that are unsurpassed in the industry."

DuPont Agricultural includes crop protection, feed, seed, food ingredient, and food safety businesses, with sales of $2.6 billion in 1997.

CuraGen completed an initial public offering in March.

Filed under

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.